Translating Science and Technology into Commercial Opportunity
Philip Kenner, Principal
In the first white paper in our series “Growing Up Biotech”, we discuss the importance of communicating a compelling product story early in a biotech's development. It may seem early for a company 10 years or more from gaining approval of its first product to begin positioning, however it’s important to implement strategies early and take a long-term view while doing so. The value story should translate scientific promise into its commercial opportunity for a biotech company’s diverse set of audiences, including partners, payers, regulators, patient advocates, and investors.